A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes

NCT07061574 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Type 1 Diabetes
New Onset

Interventions

DRUG: Anti-thymocyte globulin (ATG)
DRUG: verapamil extended-release capsule
DRUG: Adalimumab

Sponsor

City of Hope Medical Center

Collaborators

[object Object]